Invention Grant
- Patent Title: Crystalline and non-crystalline forms of SGLT2 inhibitors
- Patent Title (中): 结晶和非结晶形式的SGLT2抑制剂
-
Application No.: US13664380Application Date: 2012-10-30
-
Publication No.: US08999941B2Publication Date: 2015-04-07
- Inventor: Julian Paul Henschke , Meng-Fen Ho , Shu-Ping Chen , Yung-Fa Chen
- Applicant: ScinoPharm Taiwan, Ltd.
- Applicant Address: TW Shan-Hua
- Assignee: ScinoPharm Taiwan, Ltd.
- Current Assignee: ScinoPharm Taiwan, Ltd.
- Current Assignee Address: TW Shan-Hua
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: C07D409/10
- IPC: C07D409/10 ; C07D409/00
Abstract:
The present invention provides amorphous forms and the crystalline complexes of SGLT2 inhibitors as a novel material, in particular in pharmaceutically acceptable form. The crystalline forms of SGLT2 inhibitor canagliflozin are designated as Forms CS1, CS2, CS3, CS4 and CS5.
Public/Granted literature
- US20130237487A1 CRYSTALLINE AND NON-CRYSTALLINE FORMS OF SGLT2 INHIBITORS Public/Granted day:2013-09-12
Information query
